
Sales at Carter’s Stores
February 2020: This case was transferred from state court to federal court. (Case No. 20-cv-1436, N.D. Cal.) January 2020: A class-action lawsuit was filed against Carter’s for allegedly misleadingly advertising…
March 2016: The named plaintiff voluntarily dismissed this action When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.. The reasons for the dismissal have not been disclosed.
February 2016: A class-action lawsuit was filed against Carter’s, Inc. and OshKosh B’gosh, Inc. for allegedly falsely advertising discounts by comparing sale prices to false market prices. Specifically, the complaint alleges that the market prices were artificially inflated and were never the original prices for products. In addition, the market prices were not the prevailing market price within the three months immediately before the advertisement, as required by California law. (Morrow et al v. Carter’s, Inc., The William Carter Company, Carter’s Retail, Inc., OshKosh B’gosh, Inc. and Does 1-50, Case No. 16-cv-345, S. D. CA.)
For more information about misleadingly advertised discounts and TINA.org’s coverage of the issue, click here.
February 2020: This case was transferred from state court to federal court. (Case No. 20-cv-1436, N.D. Cal.) January 2020: A class-action lawsuit was filed against Carter’s for allegedly misleadingly advertising…
In April 2019, a class-action lawsuit was filed against the baby and children’s clothing retailer Carter’s for allegedly sending customers an email advertisement misleadingly representing that the retailer was offering…
In May 2016, a class-action lawsuit was filed against Carter’s and OshKosh B’gosh for allegedly misleadingly advertising discounts on children’s apparel and accessories sold in retail and outlet stores. Specifically,…
Company marketing ‘height growth vitamins’ makes some tall claims.
Seven terms that may apply to that enticing free bet offer.
Company removes FDA logo in response to TINA.org inquiry.
Hangover relief claims are disease-treatment claims requiring FDA approval.
More than 150 class-action lawsuits have been filed against regional and national banks.